| 产品详情 |
| Edit |   |
| Product Name | RyR-Calstabin Interaction Stabilizer, S107 |
| Description | Purity ≥98% (HPLC). A cell-permeable, orally active benzothiazepine that effectively blocks leaky intracellular calcium release by preventing the dissociation/depletion of calstabin from the ryanodine receptor (RyR) complex due to receptor modifications, such as oxidation, S-nitrosylation, hyperphosphorylation, or mutation (complete blockage of 1 mM tetracaine-induced leakage in murine RyR2 S2808D+/+ myocytes at 1uM). Shown to prevent stress-induced cognitive dysfunction by stabilizing RyR2-calstabin-2 (FKBP12.6) interaction in brain (75mg/kg/day; p.o.) and maintain exercise capacity by stabilizing RyR1-calstabin-1 (FKBP12) interaction in skeletal muscle (2.5ug/0.25uL/h/animal; s.c) in mice, as well as restore normal cardiac function (20mg/kg/day; s.c) in mice with R2474S or S2808D RyR2 mutation in vivo. Synonyms: 7-methoxy-4-methyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine, Ryanodine Receptor Stabilizer; Rycal S107 |
| Size | 10mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | RyR-Calstabin Interaction Stabilizer, S107 (7-methoxy-4-methyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine, Ryanodine Receptor Stabilizer; Rycal S107) |
| Gene, Accession, CAS # | n/a |
| Catalog # | 217763 |
| Price | |
| Order / More Info | RyR-Calstabin Interaction Stabilizer, S107 from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|